SYNERGISM BETWEEN 5-FLUOROURACIL AND N-METHYLFORMAMIDE IN HT29 HUMAN COLON CANCER LINE

被引:8
|
作者
LAUDONIO, N
ZUPI, G
ERBA, E
LEONETTI, C
DINCALCI, M
机构
[1] MARIO NEGRI INST PHARMACOL RES,VIA ERITREA 62,I-20157 MILAN,ITALY
[2] IST REGINA ELENA STUDIO & CURA TUMORI,I-00161 ROME,ITALY
关键词
D O I
10.1038/bjc.1990.82
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In HT29 cells 5-fluorouracil (5FU) cytotoxicity is enhanced by subsequent incubation of cells in medium containing 1% A-methylformamide (NMF). This enhancement does not appear to be related to differences in the repair of 5FU-induced DNA damage. It is proposed that the inhibition of DNA synthesis by NMF (that is reversible and does not result in any detectable toxicity) becomes a lethal event in a cell in which DNA synthesis has already been altered by 5FU exposure. The synergism is sequence dependent (i.e. it does not occur when NMF is given before 5FU) and specific for some cell types as shown by the fact that no synergism was found in LI210 mouse leukaemia cells. In nude mice transplanted s.c. with HT29 cells daily 5FU treatment (for 5 days) followed by daily NMF treatment (for 10 days) caused much greater inhibition of tumour growth than either drug alone or the same combination given in the opposite order (NMF then 5FU). These results, if confirmed on other human colon tumours, could be of clinical interest as a means of increasing the therapeutic efficacy of 5FU in patients with colon cancer. © Macmillan Press Ltd., 1990.
引用
收藏
页码:377 / 381
页数:5
相关论文
共 50 条
  • [1] Biological properties and expression of mucins in 5-fluorouracil resistant HT29 human colon cancer cells
    Choi, SR
    Cho, M
    Kim, HR
    Ahn, DH
    Sleisenger, MH
    Kim, YS
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (01) : 141 - 147
  • [2] THE MECHANISM OF SYNERGISM BETWEEN 5-FLUOROURACIL AND 2-OXOHEXYL ISOTHIOCYANATE IN THE COLON CANCER CELL LINE HT-29
    Milczarek, M.
    Wiktorska, K.
    Sliwka, L.
    Lubelska, K.
    Dabrowska, K.
    Matosiuk, D.
    Chilmonczyk, Z.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6060 - 6061
  • [3] MODULATION OF THE CYTO-TOXIC EFFECT OF 5-FLUOROURACIL BY N-METHYLFORMAMIDE ON A HUMAN-COLON CARCINOMA CELL-LINE
    ZUPI, G
    MARANGOLO, M
    ARANCIA, G
    GRECO, C
    LAUDONIO, N
    IOSI, F
    FORMISANO, G
    MALORNI, W
    CANCER RESEARCH, 1988, 48 (21) : 6193 - 6200
  • [4] EFFECT OF 5-FLUOROURACIL ON METHOTREXATE TRANSPORT AND CYTOTOXICITY IN HT29 COLON ADENOCARCINOMA CELLS
    CHEN, MF
    CHEN, LT
    BOYCE, HW
    CANCER LETTERS, 1995, 88 (02) : 133 - 140
  • [5] Methoxyamine Enhances 5-Fluorouracil-Induced Radiosensitization in Colon Cancer Cell Line HT29
    Khoei, Samideh
    Poorabdollahi, Roghayeh
    Mostaar, Ahmad
    Faeghi, Fariborz
    CELL JOURNAL, 2017, 19 (02) : 283 - 291
  • [6] The action of 5-fluorouracil on human HT29 colon cancer cells grown in SCID mice: mitosis, apoptosis and cell differentiation
    R Sharma
    E Adam
    U Schumacher
    British Journal of Cancer, 1997, 76 : 1011 - 1016
  • [7] The action of 5-fluorouracil on human HT29 colon cancer cells grown in SCID mice: mitosis, apoptosis and cell differentiation
    Sharma, R
    Adam, E
    Schumacher, U
    BRITISH JOURNAL OF CANCER, 1997, 76 (08) : 1011 - 1016
  • [8] Monitoring of the intracellular activation of 5-fluorouracil to deoxyribonucleotides in HT29 human colon cell line: application to modulation of metabolism and cytotoxicity study
    Ciccolini, J
    Peillard, L
    Aubert, C
    Formento, P
    Milano, G
    Catalin, J
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2000, 14 (02) : 147 - 154
  • [9] Potentiation of pro-apoptotic effect of 5-Fluorouracil on HT29 colon cancer cells by inhibition of autophagy
    Sasaki, Kazuhito
    Tsuno, Nelson
    Sunami, Eiji
    Tsurita, Giichiro
    Okaji, Yurai
    Nishikawa, Takeshi
    Syuno, Yasutaka
    Hongo, Kumiko
    Kitayama, Joji
    Takahashi, Koki
    Nagawa, Hirokazu
    CANCER RESEARCH, 2009, 69
  • [10] Paclitaxel and N-methylformamide: In vitro interactions in human colon cancer cell line
    Valenti, AM
    Niero, A
    Monti, G
    Marangolo, F
    Marangolo, M
    ANTICANCER RESEARCH, 1997, 17 (4A) : 2491 - 2497